Hearing Loss Disease Portal


 
Switch to table view
Most Common: Hearing Loss (D034381), Deafness (D003638), Sensorineural HL (D006319), Waardenburg Syndrome, Usher Syndromes
Disease Browser
Parent Node:
expand
Disorders of Sex Development (D012734)
..Starting node
..expand
46, XY Disorders of Sex Development (D058490)

       Child Nodes:
........expand17-Hydroxysteroid Dehydrogenase Deficiency (C537805) Child1
........expand46,Xy True Hermaphroditism, Sry-Related (C567575)
........expandAndrogen-Insensitivity Syndrome (D013734) Child2
........expandDenys-Drash Syndrome (D030321)
........expandFrasier Syndrome (D052159)
........expandGonadal Dysgenesis, 46,XY (D006061) Child18
........expandKallmann Syndrome (D017436) Child9
........expandLeydig Cell Hypoplasia (C562567)
........expandLipoid congenital adrenal hyperplasia (C537027)
........expandMale pseudohermaphroditism due to defective LH molecule (C535692)
........expandMale pseudohermaphroditism/mental retardation syndrome, Verloes type (C535693)
........expandNivelon Nivelon Mabille syndrome (C536123)
........expandPersistent Mullerian duct syndrome (C536665)
........expandPseudovaginal Perineoscrotal Hypospadias (C535830)
........expandUrioste Martinez-Frias syndrome (C536478)
........expandWAGR Syndrome (D017624) Child2



 Sister Nodes: 
..expand46, XX Disorders of Sex Development (D058489) Child25
..expand46, XY Disorders of Sex Development (D058490) Child48
..expandAdrenogenital Syndrome (D047808) Child17
..expandCampomelic Dysplasia with Autosomal Sex Reversal (C564282)
..expandGonadal Dysgenesis (D006059) Child37
..expandMeacham Syndrome (C563821)
..expandOvotesticular Disorders of Sex Development (D050090) Child3
..expandSex Chromosome Disorders of Sex Development (D058533) Child8
..expandVerloes Gillerot Fryns syndrome (C536539)
   

Human Disease MESH is developed by UMLS.
Further data from MedGen, OMIM, CTD
Term ID:34
Name:46, XY Disorders of Sex Development
Definition:Congenital conditions in individuals with a male karyotype, in which the development of the gonadal or anatomical sex is atypical.
Alternative IDs:OMIM:612965
ParentIDs:MESH:D012734
TreeNumbers:C12.706.316.096 |C13.351.875.253.096 |C16.131.939.316.096 |C19.391.119.096 |F03.800.399.750
Synonyms:46,XY Disorders of Sex Development |46, XY DSD |46,XY DSD |46,XY DSDs |46,XY Gonadal Dysgenesis, Complete or Partial, With or Without Adrenal Failure |46,XY Sex Reversal 3 |46,XY Sex Reversal, Partial or Complete, NR5A1-Related |Disorder of Sex Development, 46,
Slim Mappings:Congenital abnormality|Endocrine system disease|Mental disorder|Urogenital disease (female)|Urogenital disease (male)
Reference: MedGen: D058490
MeSH: D058490
OMIM: 612965;

Genes: NR5A1;
Phenotypes
1 HP:0001470Sex-limited autosomal dominant
2 HP:0000062Ambiguous genitaliaHP:0040283
3 HP:0008665Clitoral hypertrophyHP:0040283
4 HP:0008232Elevated circulating follicle stimulating hormone level
5 HP:0011969Elevated circulating luteinizing hormone level
6 HP:0000133Gonadal dysgenesis
7 HP:0000013Hypoplasia of the uterusHP:0040283
8 HP:0000808Penoscrotal hypospadias
9 HP:0012245Sex reversal
10 HP:0005092Streaky metaphyseal sclerosis
Disease Causing ClinVar Variants
Variation_NameGeneIDGeneSymbolClinicalSignificancedbSNPRCVaccessionTestedInGTRPhenotypeIDsChromosomeStartStopHGVS_cHGVS_pHGVS_gOtherIDsDisease_ClinVarDisease_hgmd
NM_004959.4(NR5A1):c.1310T>A (p.Leu437Gln)2516NR5A1Pathogenic104894120RCV000013647; NMedGen:C2751824,OMIM:612965,ORPHA:980859127245113127245113NM_004959.4:c.1310T>ANP_004950.2:p.Leu437GlnNC_000009.11:g.127245113A>TOMIM Allelic Variant:184757.0010C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.1210T>G (p.Tyr404Asp)2516NR5A1Pathogenic863224904RCV000199384; NMedGen:C2751824,OMIM:612965,ORPHA:980859127245213127245213NM_004959.4:c.1210T>GNP_004950.2:p.Tyr404AspNC_000009.11:g.127245213A>C-C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.877G>A (p.Asp293Asn)2516NR5A1Pathogenic121918655RCV000013651; RCV000013650; NMedGen:C2751824,OMIM:612965,ORPHA:98085; MedGen:C2751825,OMIM:6129649127255422127255422NM_004959.4:c.877G>ANP_004950.2:p.Asp293AsnNC_000009.11:g.127255422C>TOMIM Allelic Variant:184757.0012C2751824 612965 46,XY sex reversal, type 3; C2751825 612964 Premature ovarian failure 7
NM_004959.4(NR5A1):c.666delC (p.Asn222Lysfs)2516NR5A1Pathogenic606231206RCV000013649; RCV000013648; NMedGen:C2751824,OMIM:612965,ORPHA:98085; MedGen:C2751825,OMIM:6129649127262573127262573NM_004959.4:c.666delCNP_004950.2:p.Asn222LysfsNC_000009.11:g.127262573delGOMIM Allelic Variant:184757.0011C2751824 612965 46,XY sex reversal, type 3; C2751825 612964 Premature ovarian failure 7
NM_004959.4(NR5A1):c.390delG (p.Pro131Argfs)2516NR5A1Pathogenic606231207RCV000013655; RCV000013654; NMedGen:C2751824,OMIM:612965,ORPHA:98085; MedGen:C2751825,OMIM:6129649127262849127262849NM_004959.4:c.390delGNP_004950.2:p.Pro131ArgfsNC_000009.11:g.127262849delCOMIM Allelic Variant:184757.0014C2751824 612965 46,XY sex reversal, type 3; C2751825 612964 Premature ovarian failure 7
NM_004959.4(NR5A1):c.275G>A (p.Arg92Gln)2516NR5A1Pathogenic104894119RCV000013640; NMedGen:C2751824,OMIM:612965,ORPHA:980859127262964127262964NM_004959.4:c.275G>ANP_004950.2:p.Arg92GlnNC_000009.11:g.127262964C>TOMIM Allelic Variant:184757.0003C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.271G>A (p.Gly91Ser)2516NR5A1Pathogenic104894126RCV000013646; NMedGen:C2751824,OMIM:612965,ORPHA:980859127262968127262968NM_004959.4:c.271G>ANP_004950.2:p.Gly91SerNC_000009.11:g.127262968C>TOMIM Allelic Variant:184757.0009C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.234G>A (p.Met78Ile)2516NR5A1Pathogenic104894125RCV000013645; NMedGen:C2751824,OMIM:612965,ORPHA:980859127265368127265368NM_004959.4:c.234G>ANP_004950.2:p.Met78IleNC_000009.11:g.127265368C>TOMIM Allelic Variant:184757.0008C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.151G>T (p.Glu51Ter)2516NR5A1Pathogenic775441984RCV000197157; NMedGen:C2751824,OMIM:612965,ORPHA:980859127265451127265451NM_004959.4:c.151G>TNP_004950.2:p.Glu51TerNC_000009.11:g.127265451C>A-C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.104_105delGCinsAA (p.Gly35Glu)2516NR5A1Pathogenic121918654RCV000013638; NMedGen:C2751824,OMIM:612965,ORPHA:980859127265497127265498NM_004959.4:c.104_105delGCinsAANP_004950.2:p.Gly35GluNC_000009.11:g.127265497_127265498delGCinsTTOMIM Allelic Variant:184757.0001C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.48C>A (p.Cys16Ter)2516NR5A1Pathogenic104894123RCV000013642; NMedGen:C2751824,OMIM:612965,ORPHA:980859127265627127265627NM_004959.4:c.48C>ANP_004950.2:p.Cys16TerNC_000009.11:g.127265627G>TOMIM Allelic Variant:184757.0005C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.43G>A (p.Val15Met)2516NR5A1Pathogenic104894124RCV000013644; NMedGen:C2751824,OMIM:612965,ORPHA:980859127265632127265632NM_004959.4:c.43G>ANP_004950.2:p.Val15MetNC_000009.11:g.127265632C>TOMIM Allelic Variant:184757.0007C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.18delC (p.Asp6Glufs)2516NR5A1Pathogenic606231205RCV000013643; NMedGen:C2751824,OMIM:612965,ORPHA:980859127265657127265657NM_004959.4:c.18delCNP_004950.2:p.Asp6GlufsNC_000009.11:g.127265657delGOMIM Allelic Variant:184757.0006C2751824 612965 46,XY sex reversal, type 3
NM_004959.4(NR5A1):c.3G>A (p.Met1Ile)2516NR5A1Pathogenic121918656RCV000013653; RCV000013652; NMedGen:C2751824,OMIM:612965,ORPHA:98085; MedGen:C2751825,OMIM:6129649127265672127265672NM_004959.4:c.3G>ANP_004950.2:p.Met1IleNC_000009.11:g.127265672C>TOMIM Allelic Variant:184757.0013C2751824 612965 46,XY sex reversal, type 3; C2751825 612964 Premature ovarian failure 7